Sandoz to expand its presence in Slovenia with new $400M plant
Generics manufacturer Sandoz has committed roughly $400 million to construct a new plant in Europe.
Sandoz has agreed to build a new biologics plant in the town of Lendava, Slovenia, which is located about 125 miles east of Slovenia’s capital of Ljubljana, near the border with Hungary. In an email to Endpoints News, a spokesperson said the plant will be used to manufacture biosimilars, but the company hasn’t yet determined which ones.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
